(Rac)-Desfesoterodine thyl acetate-PEG1-methyl acetate DB1976 treatment leads to a

DB1976 treatment leads to a significant decrease in the number of viable cells (primary human AML cells) (mean decrease of 81%) and clonogenic capacity (mean decrease of 36%) compared with vehicle-treated cells

VEGF and IL-6

comprising a cereblon-binding moiety joined by a linker to gefitinib

) has minimal

in resistant cancer cell lines such as HCT116 and MDA-MB-453

(Rac)-Desfesoterodine thyl acetate-PEG1-methyl acetate DB1976 treatment leads to aProduct information CAS Number: 1185071 13 9 Molecular Weight: 355. 57 Formula: C22H31NO2 Chemical Name: 2 (3 {bis[(1,1,1,2,3,3,3 H)propan 2 yl]amino} 1 phenylpropyl) 4 (hydroxymethyl)phenol Smiles: [2H]C([2H])([2H])C([2H])(N(CCC(C1=CC(CO)=CC=C1O)C1C=CC=CC=1)C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])C([2H])([2H])[2H] InChiKey: DUXZAXCGJSBGDW UWDFEEFGSA N InChi: InChI=1S C22H31NO2 c1 16(2)23(17(3)4)13 12 20(19 8 6 5 7 9 19)21 14 18(15 24)10 11